123 related articles for article (PubMed ID: 20674)
1. Structure-activity relationships of some selected beta-adrenergic blocking agents--oxidation with N-bromosuccinimide.
Trieff NM; Venkatasubramanian N; Sadagopa Ramanujam VM; Young TR; Levy B
Tex Rep Biol Med; 1976; 34(2-4):315-29. PubMed ID: 20674
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of the pA2 of various beta blocking agents].
Spach MO; Miesch F; Schwartz J
Nouv Presse Med; 1975 Dec; 4(46 Suppl):3221-2. PubMed ID: 3766
[TBL] [Abstract][Full Text] [Related]
3. [Biotransformation and pharmacokinetics of beta-receptor blockaders].
Pfeifer S; Zimmer C
Pharmazie; 1975 Oct; 30(10):625-33. PubMed ID: 685
[No Abstract] [Full Text] [Related]
4. Comparative antihypertensive effects and tissue distribution of beta adrenergic blocking drugs.
Garvey HL; Ram N
J Pharmacol Exp Ther; 1975 Jul; 194(1):220-33. PubMed ID: 1151751
[TBL] [Abstract][Full Text] [Related]
5. Comparison of beta-adrenergic blocking activities of propranolol, isopropylmethoxamine, sotalol, practolol, alprenolol, pindolol, oxprenolol and D-32 in the atria and trachea of the guinea-pig.
Horii D; Kawada T; Takeda K; Imai S
Arzneimittelforschung; 1974 Sep; 24(9):1275-7. PubMed ID: 4154764
[No Abstract] [Full Text] [Related]
6. Central hemodynamics of beta-adrenoceptor blocking drugs: beta 1 selectivity versus intrinsic sympathomimetic activity.
Svendsen TL
J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S21-5. PubMed ID: 6188916
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
[TBL] [Abstract][Full Text] [Related]
8. [Comparative pharmacokinetics of beta-blockers].
Kiechel JR; Meier J
Nouv Presse Med; 1978 Sep; 7(31):2685-7. PubMed ID: 30943
[No Abstract] [Full Text] [Related]
9. Pindolol: a pharmacokinetic comparison with other beta-adrenoceptor blocking agents.
Meier J
Acta Med Scand Suppl; 1977; 606():65-70. PubMed ID: 19931
[No Abstract] [Full Text] [Related]
10. [Pharmacological basis for the therapy of cardiovascular disease with beta-adrenoceptor blocking drugs (author's transl)].
Lemmer B
Herz; 1982 Jun; 7(3):168-78. PubMed ID: 6124492
[TBL] [Abstract][Full Text] [Related]
11. The receptor binding profile of the new antihypertensive agent nebivolol and its stereoisomers compared with various beta-adrenergic blockers.
Pauwels PJ; Gommeren W; Van Lommen G; Janssen PA; Leysen JE
Mol Pharmacol; 1988 Dec; 34(6):843-51. PubMed ID: 2462161
[TBL] [Abstract][Full Text] [Related]
12. Protection against isoprenaline induced myocardial necroses by beta-adrenergic blocking agents.
Kulig A; Kostka-Trabka E; Gryglewski R
Pol J Pharmacol Pharm; 1973; 25(1):85-90. PubMed ID: 4149575
[No Abstract] [Full Text] [Related]
13. Oxidation of beta-blocking agents. V. Light-influenced oxidation of propranolol and its glycol with N-bromosuccinimide.
Salomies H
Acta Pharm Suec; 1987; 24(4):193-8. PubMed ID: 2894109
[No Abstract] [Full Text] [Related]
14. Relationship between pharmacokinetics and pharmacodynamics of the beta adrenergic blocking drug sotalol in dogs.
Ishizaki T; Tawara K
J Pharmacol Exp Ther; 1979 Nov; 211(2):331-7. PubMed ID: 501565
[TBL] [Abstract][Full Text] [Related]
15. Central actions of some beta-adrenoceptor blocking agents.
Shah UH; Jindal MN; Patel VK; Kelkar VV
Arzneimittelforschung; 1974 Oct; 24(10):1581-4. PubMed ID: 4154760
[No Abstract] [Full Text] [Related]
16. Propranolol in the treatment of angina: a review.
Prichard BN
Postgrad Med J; 1976; 52 Suppl 4():35-41. PubMed ID: 787954
[TBL] [Abstract][Full Text] [Related]
17. New perspectives in cardiopulmonary therapeutics: receptor-selective adrenergic drugs.
Adams HR
J Am Vet Med Assoc; 1984 Nov; 185(9):966-74. PubMed ID: 6150925
[TBL] [Abstract][Full Text] [Related]
18. Effect of different beta-blocking agents on an in vitro model of ventricular automaticity.
Hernández J; Serrano JS
Methods Find Exp Clin Pharmacol; 1982; 4(5):307-11. PubMed ID: 6126623
[TBL] [Abstract][Full Text] [Related]
19. The effects of (+/-)-, (+)-, and (-)-atenolol, sotalol, and amosulalol on the rat left atria and portal vein.
Doggrell SA
Chirality; 1993; 5(1):8-14. PubMed ID: 8095397
[TBL] [Abstract][Full Text] [Related]
20. Effects of selective and nonselective beta adrenergic agents on renin secretion in isolated perfused rat kidney.
Nakane H; Nakane Y; Roux A; Corvol P; Menard J
J Pharmacol Exp Ther; 1980 Jan; 212(1):34-8. PubMed ID: 6101342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
